Controversies in neurology, Vienna, 2012: Steroids in bacterial meningitis: no

作者: Bettina Pfausler , Erich Schmutzhard

DOI: 10.1007/S00702-012-0939-Z

关键词:

摘要: In acute bacterial meningitis long-term morbidity and mortality are still high, in particular, low middle income countries where meningococci the most frequent causative agents of this disease. If at all, dexamethasone has been shown to be helpful pneumococcal meningitis, i.e., elderly Europeans not adolescent African, Asian or South American patients. Since deranged glucose, glucose variability coagulation homeostasis known deleterious patients with dexamethasone—being capable cause both—might add mortality. After more than 20 prospective trials evidence lacks that improves outcome majority Dexamethasone only exerts a positive effect, if given prior first dose antibiotic; therefore, introduction empiric antimicrobial chemotherapy into emergency (= pre-hospital) management suspected discussion on is rendered almost futile.

参考文章(24)
Emma CB Wall, Katherine MB Ajdukiewicz, Robert S Heyderman, Paul Garner, Osmotic therapies as adjuncts to antibiotics for acute bacterial meningitis John Wiley & Sons, Ltd. ,(2010) , 10.1002/14651858.CD008806
Rasmus Køster-Rasmussen, André Korshin, Christian N. Meyer, Antibiotic treatment delay and outcome in acute bacterial meningitis Journal of Infection. ,vol. 57, pp. 449- 454 ,(2008) , 10.1016/J.JINF.2008.09.033
Maarten Moens, G. Van Berlaer, Herbert Spapen, Ives Hubloue, Adjunctive steroid treatment in acute bacterial meningitis. "To do or not to do: that is the question". Acta Clinica Belgica. ,vol. 66, pp. 42- 45 ,(2011) , 10.2143/ACB.66.1.2062512
Kupper A. Wintergerst, Michael B. Foster, Janice E. Sullivan, Charles R. Woods, Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit. Journal of diabetes science and technology. ,vol. 6, pp. 5- 14 ,(2012) , 10.1177/193229681200600102
Juri Katchanov, Peter U. Heuschmann, Matthias Endres, Jörg R. Weber, Cerebral infarction in bacterial meningitis: predictive factors and outcome. Journal of Neurology. ,vol. 257, pp. 716- 720 ,(2010) , 10.1007/S00415-009-5395-9
Yuji Kato, Hidetaka Takeda, Tomohisa Dembo, Norio Tanahashi, Delayed recurrent ischemic stroke after initial good recovery from pneumococcal meningitis. Internal Medicine. ,vol. 51, pp. 647- 650 ,(2012) , 10.2169/INTERNALMEDICINE.51.6315
Paul Daza, Richard Banda, Keystoxe Misoya, Agnes Katsulukuta, Bradford D. Gessner, Reggis Katsande, Bekithemba R. Mhlanga, Judith E. Mueller, Christopher B. Nelson, Amos Phiri, Elizabeth M. Molyneux, Malcolm E. Molyneux, The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence Vaccine. ,vol. 24, pp. 6232- 6239 ,(2006) , 10.1016/J.VACCINE.2006.05.076
Scott A. Halperin, Julie A. Bettinger, Brian Greenwood, Lee H. Harrison, Jane Jelfs, Shamez N. Ladhani, Peter McIntyre, Mary E. Ramsay, Marco A.P. Sáfadi, The changing and dynamic epidemiology of meningococcal disease. Vaccine. ,vol. 30, ,(2012) , 10.1016/J.VACCINE.2011.12.032
Ewout S Schut, Willeke F Westendorp, Jan de Gans, Nyika D Kruyt, Lodewijk Spanjaard, Johannes B Reitsma, Diederik van de Beek, Hyperglycemia in bacterial meningitis: a prospective cohort study BMC Infectious Diseases. ,vol. 9, pp. 57- 57 ,(2009) , 10.1186/1471-2334-9-57